Dopamine agonists for treating elevated intraocular pressure

Details Dopamine agonists for treating elevated intraocular pressure Dopamine agonists for treating elevated intraocular pressure

1985-12-24

1988-09-27

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514227, 514913, A61K 31535

Patent

active

047742437

ABSTRACT:
Topical ocular administration of a dopamine agonist is effective in lowering abnormally elevated intraocular pressure and is useful in the prevention and treatment of glaucoma and related ocular diseases.

REFERENCES:
patent: 4238486 (1980-12-01), Jones
patent: 4349548 (1982-09-01), Jones
patent: 4420480 (1983-12-01), Jones
patent: 4493836 (1985-01-01), Nedelec et al.
patent: 4503053 (1985-03-01), Nedelec et al.
Mekki et al., The Lancet, 1250, (1983).
Potter et al., Cur. Eye. Res., 2, 281, (1983).
Macri et al., Exp. Eye Res., 26, 85, (1978).
Green et al., Exp. Eye Res., 29, 423, (1979).
Potter et al., Cur. Eye Res., 3, 851, (1984).
Shannon et al., Ophthalmol., 15, 371, (1976).

Affiliated with

Also associated with

Rating

Dopamine agonists for treating elevated intraocular pressure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopamine agonists for treating elevated intraocular pressure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine agonists for treating elevated intraocular pressure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2398120